Brief: Kelun-Biotech Receives A Clinical Trial Notice For Its First Dual-Payload Adc Skb565
27/07/2026 12:37
BRIEF-Kelun-Biotech Receives A Clinical Trial Notice For Its First Dual-Payload Adc Skb565 July 27 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:
KELUN-BIOTECH RECEIVES A CLINICAL TRIAL NOTICE FOR ITS FIRST DUAL-PAYLOAD ADC SKB565
Source text: ID:nPn34nH92a
Further company coverage: 6990.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sichuan Kelun-Biotech Biopharmaceutical
See all newsBrief: Sichuan Kelun-Biotech Biopharmaceutical Subscribes To CZB Structured Deposit VI For RMB500 Mln
Brief: Sichuan Kelun-Biotech Biopharmaceutical Says NMPA Accepts New Indication Application For SAC-TMT
Brief: Kelun-Biotech's Partner Windward Bio Announces Positive Phase 2 Results Of Skb378/Win378 In Asthma, And Initiates Phase 3 Study
China's Sichuan Kelun-Biotech swings to profit in H1 on new product approvals
Brief: Sichuan Kelun-Biotech Biopharmaceutical Posts HY Net Income Attributable Of RMB 388 MLN